Feature|Videos|February 19, 2025 (Updated: February 26, 2025)
Accelerate Inclusive Enrollment and Delivery with Lightship
Author(s)Lightship
David MacMurchy, Chief Executive Officer at Lightship, offers some insights into the company's mission toward improving equity and diversity in clinical trials.
Lightship focuses on patient accessibility and centricity in clinical trials, ensuring the patient experience is a positive one. Learn more about:
- Lightship's impact on achieving diversity in clinical trials by engaging underrepresented patient populations
- How Lightship utilizes hybrid and decentralized trial designs to reduce patient burden
- The impact a patient centric model has on clinical trial participation and outcomes
Related Content
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
5